Skip to content

Insider · CIK 0001775295

Christine Chung

officer

Files at KYNB (KYNTRA BIO, INC.). First filing -, latest -.

Christine Chung files SEC Form 4 as officer at KYNB (KYNTRA BIO, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Christine Chung has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 6, 2025KYNB
KYNTRA BIO, INC.
FTax withholding
Common Stock
-7,008$0.39$2,733294,544Mar 7, 2025
Mar 6, 2025KYNB
KYNTRA BIO, INC.
AGrant or award
Common Stock
+781$0.00$0295,325Mar 7, 2025
Mar 6, 2025KYNB
KYNTRA BIO, INC.
FTax withholding
Common Stock
-422$0.39$165294,903Mar 7, 2025
Dec 6, 2024KYNB
KYNTRA BIO, INC.
FTax withholding
Common Stock
-2,792$0.34$955301,552Dec 9, 2024

Questions about Christine Chung

Answered from the filings on this page, as of the latest one.

Is Christine Chung buying or selling?

Christine Chung has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Christine Chung's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Chung has 0.

Where does Christine Chung file Form 4?

Christine Chung has filed Form 4 at KYNB (KYNTRA BIO, INC.) as SVP, CHINA OPERATIONS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christine Chung: insider trades and track record | InsiderTell